Literature DB >> 4587748

Conditions for immunosuppression by rifampicin.

L Bassi, L Di Berardino, V Arioli, L G Silvestri, E L Lignière.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4587748     DOI: 10.1093/infdis/128.6.736

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  9 in total

Review 1.  Antibiotic agents and the immune mechanisms of defense.

Authors:  J W Alexander
Journal:  Bull N Y Acad Med       Date:  1975-10

2.  Immunosuppressant activity of the ansamycins.

Authors:  J E Kasik; M Monick; J S Thompson
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

3.  Antibiotics and suppression of lymphocyte function in vitro.

Authors:  G Banck; A Forsgren
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

Review 4.  Cell-mediated immunity and its role in resistance to infection.

Authors:  E J Wing; J S Remington
Journal:  West J Med       Date:  1977-01

5.  Effect of rifampin on the immune response in mice.

Authors:  A Bellahsène; A Forsgren
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

6.  Immunological responsiveness of tuberculosis patients receiving rifampin.

Authors:  F L Ruben; A Winkelstein; I G Fotiadis
Journal:  Antimicrob Agents Chemother       Date:  1974-04       Impact factor: 5.191

7.  Therapy of murine aspergillosis with amphotericin B in combination with rifampin of 5-fluorocytosine.

Authors:  J Arroyo; G Medoff; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

8.  Effect of rifampin on immunity to tuberculosis and on delayed hypersensitivity to purified protein derivative.

Authors:  A S Youmans; G P Youmans; D Cahall
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

9.  Rifampicin-induced suppression of antitumor immunity.

Authors:  W Roszkowski; R Lipinska; K Roszkowski; J Jeljaszewicz; G Pulverer
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.